PENNATI, MARZIA
 Distribuzione geografica
Continente #
EU - Europa 288
NA - Nord America 253
AS - Asia 88
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 632
Nazione #
US - Stati Uniti d'America 252
DE - Germania 124
GB - Regno Unito 75
CN - Cina 46
SE - Svezia 28
IT - Italia 23
SG - Singapore 16
IN - India 13
IE - Irlanda 9
DK - Danimarca 8
FR - Francia 7
BE - Belgio 4
FI - Finlandia 4
JP - Giappone 4
KR - Corea 3
ID - Indonesia 2
NO - Norvegia 2
UA - Ucraina 2
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
HK - Hong Kong 1
IR - Iran 1
KE - Kenya 1
MX - Messico 1
TR - Turchia 1
VN - Vietnam 1
Totale 632
Città #
Frankfurt am Main 109
Southend 65
Chandler 53
Woodbridge 17
Fairfield 16
Wilmington 16
Ann Arbor 14
Milan 14
Ashburn 13
Cambridge 13
Houston 13
Princeton 12
Seattle 12
Beijing 10
Falls Church 10
Dearborn 9
Dublin 8
Singapore 7
Munich 6
Nanjing 6
Des Moines 5
Shenyang 5
Bengaluru 4
Brussels 4
Jinan 4
Mumbai 4
Phoenix 4
Redwood City 3
Boardman 2
Changsha 2
Chengdu 2
Chicago 2
Eitensheim 2
Gävle 2
Jakarta 2
London 2
Nanchang 2
New York 2
Philadelphia 2
Tokyo 2
Zhengzhou 2
Andover 1
Buffalo 1
Bühl 1
Central District 1
Clarks Summit 1
Cork 1
Fremont 1
Fuzhou 1
Göteborg 1
Hangzhou 1
Hanoi 1
Hebei 1
Heidelberg 1
Helsinki 1
Jiaxing 1
Kunming 1
Madison 1
Mannheim 1
Mountain View 1
Pescia 1
Puebla City 1
Shanghai 1
Silver Spring 1
Speyer 1
Stavanger 1
Totale 507
Nome #
miR-21: an oncomir on strike in prostate cancer 152
Evaluation of mediators associated with the inflammatory response in prostate cancer patients undergoing radiotherapy 151
MiR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells 108
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial 97
Design of Allosteric Stimulators of the Hsp90 ATPase as New Anticancer Leads 92
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer : an open label, single-group, phase 2 trial 75
Totale 675
Categoria #
all - tutte 1.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020124 16 4 2 19 6 12 15 13 20 11 4 2
2020/202175 7 8 5 7 7 4 8 7 9 4 5 4
2021/202280 5 2 2 1 8 15 7 4 8 5 7 16
2022/2023114 9 17 16 13 13 17 4 7 15 1 2 0
2023/2024156 1 4 2 2 17 4 24 19 9 23 25 26
Totale 675